$ESRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Express Scripts Holding Co..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Express Scripts Holding Co.. Get notifications about new insider transactions in Express Scripts Holding Co. for free.
Page: < prev 1 2 3 4 5 6 7 ... 9 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 04 2018 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Option Exercise | M | 0.00 | 159 | 0 | 1,329 | |
Jan 04 2018 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Option Exercise | I | 0.00 | 635 | 0 | 1,488 | |
Jan 04 2018 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Payment of Exercise | F | 75.23 | 49 | 3,686 | 37,164 | 37.2 K to 37.2 K (-0.13 %) |
Jan 04 2018 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Buy | M | 75.23 | 158 | 11,886 | 37,213 | 37.1 K to 37.2 K (+0.43 %) |
Jan 04 2018 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Sell | S | 76.00 | 3,448 | 262,048 | 37,055 | 40.5 K to 37.1 K (-8.51 %) |
Dec 19 2017 | ESRX | Express Scripts Ho ... | HAVEL JAMES M | Executive VP and CF ... | Grant | A | 0.00 | 34,940 | 0 | 34,940 | 0 to 34.9 K |
Dec 18 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Option Exercise | M | 56.50 | 10,104 | 570,876 | 0 | |
Dec 18 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Sell | S | 70.08 | 10,104 | 708,048 | 77,296 | 87.4 K to 77.3 K (-11.56 %) |
Dec 18 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Buy | M | 56.50 | 10,104 | 570,876 | 87,400 | 77.3 K to 87.4 K (+13.07 %) |
Dec 05 2017 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Payment of Exercise | F | 64.41 | 121 | 7,794 | 45,912 | 46 K to 45.9 K (-0.26 %) |
Dec 05 2017 | ESRX | Express Scripts Ho ... | Akins Martin P. | Sr. VP & General Co ... | Payment of Exercise | F | 64.41 | 769 | 49,531 | 27,541 | 28.3 K to 27.5 K (-2.72 %) |
Oct 31 2017 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Buy | P | 61.13 | 8,000 | 489,002 | 106,628 | 98.6 K to 106.6 K (+8.11 %) |
Oct 31 2017 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Gift | G | 0.00 | 107,452 | 0 | 107,452 | 0 to 107.5 K |
Oct 31 2017 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Gift | G | 0.00 | 107,452 | 0 | 98,628 | 206.1 K to 98.6 K (-52.14 %) |
Oct 31 2017 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Payment of Exercise | F | 61.35 | 322 | 19,755 | 10,280 | 10.6 K to 10.3 K (-3.04 %) |
Sep 15 2017 | ESRX | Express Scripts Ho ... | Phillips Bradley E | VP, Controller and ... | Grant | A | 0.00 | 3,162 | 0 | 11,068 | 7.9 K to 11.1 K (+39.99 %) |
Sep 15 2017 | ESRX | Express Scripts Ho ... | Phillips Bradley E | VP, Controller and ... | Grant | A | 0.00 | 7,906 | 0 | 7,906 | 0 to 7.9 K |
Sep 12 2017 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Payment of Exercise | F | 62.90 | 745 | 46,861 | 35,904 | 36.6 K to 35.9 K (-2.03 %) |
Sep 12 2017 | ESRX | Express Scripts Ho ... | MYERS WOODROW A JR | Director | Sell | S | 63.93 | 3,900 | 249,343 | 11,500 | 15.4 K to 11.5 K (-25.32 %) |
Sep 12 2017 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Sell | S | 63.13 | 578 | 36,490 | 10,530 | 11.1 K to 10.5 K (-5.20 %) |
Aug 25 2017 | ESRX | Express Scripts Ho ... | Neville Everett | Sr. VP, Sup. Chain ... | Sell | S | 61.48 | 1,163 | 71,501 | 18,232 | 19.4 K to 18.2 K (-6.00 %) |
May 23 2017 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Sell | S | 60.08 | 1,100 | 66,088 | 11,108 | 12.2 K to 11.1 K (-9.01 %) |
May 15 2017 | ESRX | Express Scripts Ho ... | STERNBERG SEYMOUR | Director | Option Exercise | A | 60.66 | 8,006 | 485,644 | 8,006 | |
May 15 2017 | ESRX | Express Scripts Ho ... | STERNBERG SEYMOUR | Director | Grant | A | 0.00 | 1,648 | 0 | 6,150 | 4.5 K to 6.2 K (+36.61 %) |
May 15 2017 | ESRX | Express Scripts Ho ... | LAHOWCHIC NICHOLAS | Director | Option Exercise | A | 60.66 | 8,006 | 485,644 | 8,006 | |
May 15 2017 | ESRX | Express Scripts Ho ... | LAHOWCHIC NICHOLAS | Director | Grant | A | 0.00 | 1,648 | 0 | 32,107 | 30.5 K to 32.1 K (+5.41 %) |
May 15 2017 | ESRX | Express Scripts Ho ... | MYERS WOODROW A JR | Director | Option Exercise | A | 60.66 | 8,006 | 485,644 | 8,006 | |
May 15 2017 | ESRX | Express Scripts Ho ... | MYERS WOODROW A JR | Director | Grant | A | 0.00 | 1,648 | 0 | 15,400 | 13.8 K to 15.4 K (+11.98 %) |
May 15 2017 | ESRX | Express Scripts Ho ... | PALMORE RODERICK A | Director | Option Exercise | A | 60.66 | 8,006 | 485,644 | 8,006 | |
May 15 2017 | ESRX | Express Scripts Ho ... | PALMORE RODERICK A | Director | Grant | A | 0.00 | 1,648 | 0 | 4,563 | 2.9 K to 4.6 K (+56.54 %) |
May 15 2017 | ESRX | Express Scripts Ho ... | ROPER WILLIAM L | Director | Option Exercise | A | 60.66 | 8,006 | 485,644 | 8,006 | |
May 15 2017 | ESRX | Express Scripts Ho ... | ROPER WILLIAM L | Director | Grant | A | 0.00 | 1,648 | 0 | 16,100 | 14.5 K to 16.1 K (+11.40 %) |
May 15 2017 | ESRX | Express Scripts Ho ... | Paz George | Director | Option Exercise | A | 60.66 | 8,006 | 485,644 | 8,006 | |
May 15 2017 | ESRX | Express Scripts Ho ... | Paz George | Director | Grant | A | 0.00 | 1,648 | 0 | 954,991 | 953.3 K to 955 K (+0.17 %) |
May 15 2017 | ESRX | Express Scripts Ho ... | DeLaney William J III | Director | Option Exercise | A | 60.66 | 8,006 | 485,644 | 8,006 | |
May 15 2017 | ESRX | Express Scripts Ho ... | DeLaney William J III | Director | Grant | A | 0.00 | 1,648 | 0 | 9,414 | 7.8 K to 9.4 K (+21.22 %) |
May 09 2017 | ESRX | Express Scripts Ho ... | Neville Everett | Sr VP-Supply Chain ... | Payment of Exercise | F | 61.58 | 384 | 23,647 | 19,395 | 19.8 K to 19.4 K (-1.94 %) |
May 09 2017 | ESRX | Express Scripts Ho ... | Mergenthaler Frank | Director | Option Exercise | M | 51.25 | 8,042 | 412,112 | 0 | |
May 09 2017 | ESRX | Express Scripts Ho ... | Mergenthaler Frank | Director | Payment of Exercise | F | 61.58 | 6,693 | 412,155 | 26,073 | 32.8 K to 26.1 K (-20.43 %) |
May 09 2017 | ESRX | Express Scripts Ho ... | Mergenthaler Frank | Director | Buy | M | 51.25 | 8,042 | 412,112 | 32,766 | 24.7 K to 32.8 K (+32.53 %) |
May 09 2017 | ESRX | Express Scripts Ho ... | MAC MAHON THOMAS P | Director | Option Exercise | M | 51.25 | 8,042 | 412,112 | 0 | |
May 09 2017 | ESRX | Express Scripts Ho ... | MAC MAHON THOMAS P | Director | Payment of Exercise | F | 61.58 | 6,693 | 412,155 | 52,930 | 59.6 K to 52.9 K (-11.23 %) |
May 09 2017 | ESRX | Express Scripts Ho ... | MAC MAHON THOMAS P | Director | Buy | M | 51.25 | 8,042 | 412,112 | 59,623 | 51.6 K to 59.6 K (+15.59 %) |
May 09 2017 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Option Exercise | M | 51.25 | 8,042 | 412,112 | 0 | |
May 09 2017 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Payment of Exercise | F | 61.58 | 6,693 | 412,155 | 20,994 | 27.7 K to 21 K (-24.17 %) |
May 09 2017 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Buy | M | 51.25 | 8,042 | 412,112 | 27,687 | 19.6 K to 27.7 K (+40.94 %) |
May 08 2017 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Payment of Exercise | F | 61.79 | 3,783 | 233,752 | 206,080 | 209.9 K to 206.1 K (-1.80 %) |
May 02 2017 | ESRX | Express Scripts Ho ... | LAHOWCHIC NICHOLAS | Director | Option Exercise | M | 51.25 | 2,682 | 137,439 | 0 | |
May 02 2017 | ESRX | Express Scripts Ho ... | LAHOWCHIC NICHOLAS | Director | Buy | M | 51.25 | 2,682 | 137,439 | 30,459 | 27.8 K to 30.5 K (+9.66 %) |
Mar 15 2017 | ESRX | Express Scripts Ho ... | Neville Everett | Sr VP-Supply Chain ... | Option Exercise | I | 0.00 | 36 | 0 | 767 | |
Mar 15 2017 | ESRX | Express Scripts Ho ... | Neville Everett | Sr VP-Supply Chain ... | Option Exercise | I | 0.00 | 25 | 0 | 731 | |
Mar 10 2017 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Option Exercise | A | 67.62 | 271,714 | 18,373,301 | 271,714 | |
Mar 10 2017 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Grant | A | 0.00 | 56,689 | 0 | 209,863 | 153.2 K to 209.9 K (+37.01 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Payment of Exercise | F | 67.62 | 17,613 | 1,190,991 | 153,174 | 170.8 K to 153.2 K (-10.31 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Grant | A | 0.00 | 36,730 | 0 | 170,787 | 134.1 K to 170.8 K (+27.40 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Option Exercise | A | 67.62 | 50,798 | 3,434,961 | 50,798 | |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Grant | A | 0.00 | 10,598 | 0 | 57,760 | 47.2 K to 57.8 K (+22.47 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Payment of Exercise | F | 67.62 | 7,123 | 481,657 | 47,162 | 54.3 K to 47.2 K (-13.12 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Grant | A | 0.00 | 14,854 | 0 | 54,285 | 39.4 K to 54.3 K (+37.67 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Option Exercise | A | 67.62 | 30,715 | 2,076,948 | 30,715 | |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Grant | A | 0.00 | 6,408 | 0 | 40,503 | 34.1 K to 40.5 K (+18.79 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Payment of Exercise | F | 67.62 | 4,160 | 281,299 | 34,095 | 38.3 K to 34.1 K (-10.87 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Grant | A | 0.00 | 9,361 | 0 | 38,255 | 28.9 K to 38.3 K (+32.40 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | SLUSSER ERIC | Exec. VP & CFO | Option Exercise | A | 67.62 | 64,975 | 4,393,610 | 64,975 | |
Mar 10 2017 | ESRX | Express Scripts Ho ... | SLUSSER ERIC | Exec. VP & CFO | Grant | A | 0.00 | 13,556 | 0 | 37,218 | 23.7 K to 37.2 K (+57.29 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Sample Neal J. | Sr. VP & Ch. Inform ... | Option Exercise | A | 67.62 | 47,254 | 3,195,315 | 47,254 | |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Sample Neal J. | Sr. VP & Ch. Inform ... | Grant | A | 0.00 | 9,859 | 0 | 28,614 | 18.8 K to 28.6 K (+52.57 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Option Exercise | A | 67.62 | 51,980 | 3,514,888 | 51,980 | |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Grant | A | 0.00 | 10,844 | 0 | 36,649 | 25.8 K to 36.6 K (+42.02 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Payment of Exercise | F | 67.62 | 5,207 | 352,097 | 25,805 | 31 K to 25.8 K (-16.79 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Grant | A | 0.00 | 11,163 | 0 | 31,012 | 19.8 K to 31 K (+56.24 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Paz George | Director | Payment of Exercise | F | 67.62 | 36,263 | 2,452,104 | 953,343 | 989.6 K to 953.3 K (-3.66 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Paz George | Director | Grant | A | 0.00 | 75,625 | 0 | 989,606 | 914 K to 989.6 K (+8.27 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Neville Everett | Sr VP-Supply Chain ... | Option Exercise | A | 67.62 | 51,980 | 3,514,888 | 51,980 | |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Neville Everett | Sr VP-Supply Chain ... | Grant | A | 0.00 | 10,844 | 0 | 19,779 | 8.9 K to 19.8 K (+121.37 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Option Exercise | A | 67.62 | 41,347 | 2,795,884 | 41,347 | |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Grant | A | 0.00 | 8,626 | 0 | 46,033 | 37.4 K to 46 K (+23.06 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Payment of Exercise | F | 67.62 | 3,420 | 231,260 | 37,407 | 40.8 K to 37.4 K (-8.38 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Grant | A | 0.00 | 7,921 | 0 | 40,827 | 32.9 K to 40.8 K (+24.07 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | McGinnis Christopher A | VP, Controller & Ch ... | Grant | A | 0.00 | 3,947 | 0 | 6,675 | 2.7 K to 6.7 K (+144.68 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Option Exercise | A | 67.62 | 64,975 | 4,393,610 | 64,975 | |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Grant | A | 0.00 | 13,556 | 0 | 77,296 | 63.7 K to 77.3 K (+21.27 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Payment of Exercise | F | 67.62 | 5,698 | 385,299 | 63,740 | 69.4 K to 63.7 K (-8.21 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Grant | A | 0.00 | 11,882 | 0 | 69,438 | 57.6 K to 69.4 K (+20.64 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Option Exercise | A | 67.62 | 23,627 | 1,597,658 | 23,627 | |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Grant | A | 0.00 | 4,929 | 0 | 12,208 | 7.3 K to 12.2 K (+67.72 %) |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Akins Martin P. | Senior VP & General ... | Option Exercise | A | 67.62 | 47,254 | 3,195,315 | 47,254 | |
Mar 10 2017 | ESRX | Express Scripts Ho ... | Akins Martin P. | Senior VP & General ... | Grant | A | 0.00 | 9,859 | 0 | 28,310 | 18.5 K to 28.3 K (+53.43 %) |
Mar 07 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Option Exercise | M | 49.50 | 10,742 | 531,675 | 0 | |
Mar 07 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Payment of Exercise | F | 71.58 | 8,871 | 634,986 | 57,556 | 66.4 K to 57.6 K (-13.35 %) |
Mar 07 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Buy | M | 49.50 | 10,742 | 531,675 | 66,427 | 55.7 K to 66.4 K (+19.29 %) |
Mar 07 2017 | ESRX | Express Scripts Ho ... | Paz George | Director | Option Exercise | M | 49.50 | 174,386 | 8,631,235 | 0 | |
Mar 07 2017 | ESRX | Express Scripts Ho ... | Paz George | Director | Payment of Exercise | F | 71.58 | 146,381 | 10,477,952 | 913,981 | 1.1 M to 914 K (-13.80 %) |
Mar 07 2017 | ESRX | Express Scripts Ho ... | Paz George | Director | Buy | M | 49.50 | 174,386 | 8,631,235 | 1,060,362 | 886 K to 1.1 M (+19.68 %) |
Mar 02 2017 | ESRX | Express Scripts Ho ... | Paz George | Director | Payment of Exercise | F | 70.65 | 16,452 | 1,162,334 | 885,976 | 902.4 K to 886 K (-1.82 %) |
Mar 02 2017 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Payment of Exercise | F | 70.65 | 1,732 | 122,366 | 32,906 | 34.6 K to 32.9 K (-5.00 %) |
Mar 02 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Payment of Exercise | F | 70.65 | 2,790 | 197,114 | 55,685 | 58.5 K to 55.7 K (-4.77 %) |
Mar 02 2017 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Payment of Exercise | F | 70.65 | 3,071 | 216,966 | 39,431 | 42.5 K to 39.4 K (-7.23 %) |
Mar 02 2017 | ESRX | Express Scripts Ho ... | SLUSSER ERIC | Exec. VP & CFO | Payment of Exercise | F | 70.65 | 1,474 | 104,138 | 23,662 | 25.1 K to 23.7 K (-5.86 %) |
Mar 02 2017 | ESRX | Express Scripts Ho ... | Sample Neal J. | Sr. VP & Ch. Inform ... | Payment of Exercise | F | 70.65 | 3,285 | 232,085 | 18,755 | 22 K to 18.8 K (-14.90 %) |
Mar 02 2017 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Payment of Exercise | F | 70.65 | 894 | 63,161 | 7,279 | 8.2 K to 7.3 K (-10.94 %) |
Mar 02 2017 | ESRX | Express Scripts Ho ... | Neville Everett | Sr VP-Supply Chain ... | Sell | S | 70.16 | 2,352 | 165,016 | 8,935 | 11.3 K to 8.9 K (-20.84 %) |
Mar 02 2017 | ESRX | Express Scripts Ho ... | Neville Everett | Sr VP-Supply Chain ... | Payment of Exercise | F | 70.65 | 1,425 | 100,676 | 11,287 | 12.7 K to 11.3 K (-11.21 %) |
Feb 03 2017 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Option Exercise | A | 0.00 | 634 | 0 | 1,692 | |
Feb 03 2017 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Gift | G | 0.00 | 6,600 | 0 | 147,016 | 153.6 K to 147 K (-4.30 %) |
Feb 03 2017 | ESRX | Express Scripts Ho ... | Wade Sara E | Sr. VP and Ch. Huma ... | Option Exercise | A | 0.00 | 279 | 0 | 1,156 | |
Feb 03 2017 | ESRX | Express Scripts Ho ... | Stettin Glen D. | Sr. VP, Clin. Res. ... | Option Exercise | A | 0.00 | 223 | 0 | 853 | |
Feb 03 2017 | ESRX | Express Scripts Ho ... | SLUSSER ERIC | Exec. VP & CFO | Option Exercise | A | 0.00 | 235 | 0 | 282 | |
Feb 03 2017 | ESRX | Express Scripts Ho ... | Sample Neal J. | Sr. VP & Ch. Inform ... | Option Exercise | A | 0.00 | 110 | 0 | 110 | |
Feb 03 2017 | ESRX | Express Scripts Ho ... | Houston Christine | Executive VP & COO | Option Exercise | A | 0.00 | 298 | 0 | 985 | |
Feb 03 2017 | ESRX | Express Scripts Ho ... | Neville Everett | Sr VP-Supply Chain ... | Option Exercise | A | 0.00 | 199 | 0 | 705 | |
Feb 03 2017 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Option Exercise | A | 0.00 | 230 | 0 | 1,819 | |
Feb 03 2017 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Option Exercise | A | 0.00 | 160 | 0 | 185 | |
Jan 05 2017 | ESRX | Express Scripts Ho ... | Neville Everett | Sr. VP, Sup. Chain ... | Sell | S | 69.41 | 1,123 | 77,947 | 12,712 | 13.8 K to 12.7 K (-8.12 %) |
Dec 05 2016 | ESRX | Express Scripts Ho ... | Akins Martin P. | Senior VP & General ... | Payment of Exercise | F | 75.83 | 769 | 58,313 | 19,824 | 20.6 K to 19.8 K (-3.73 %) |
Dec 05 2016 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Payment of Exercise | F | 75.83 | 179 | 13,574 | 34,638 | 34.8 K to 34.6 K (-0.51 %) |
Nov 14 2016 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Option Exercise | M | 49.50 | 21,798 | 1,078,892 | 0 | |
Nov 14 2016 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Sell | S | 75.02 | 21,798 | 1,635,351 | 34,817 | 56.6 K to 34.8 K (-38.50 %) |
Nov 14 2016 | ESRX | Express Scripts Ho ... | Miller Steven B | Sr. VP & Chief Med. ... | Buy | M | 49.50 | 21,798 | 1,078,892 | 56,615 | 34.8 K to 56.6 K (+62.61 %) |
Nov 14 2016 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Sell | S | 74.74 | 642 | 47,983 | 8,173 | 8.8 K to 8.2 K (-7.28 %) |
Nov 04 2016 | ESRX | Express Scripts Ho ... | Anderson Phyllis S. | Sr. VP & Ch. Market ... | Payment of Exercise | F | 65.09 | 322 | 20,959 | 8,815 | 9.1 K to 8.8 K (-3.52 %) |
Sep 16 2016 | ESRX | Express Scripts Ho ... | MYERS WOODROW A JR | Director | Option Exercise | M | 61.58 | 4,000 | 246,320 | 1,872 | |
Sep 16 2016 | ESRX | Express Scripts Ho ... | MYERS WOODROW A JR | Director | Option Exercise | M | 52.53 | 6,870 | 360,881 | 0 | |
Sep 16 2016 | ESRX | Express Scripts Ho ... | MYERS WOODROW A JR | Director | Option Exercise | M | 57.59 | 1,166 | 67,150 | 0 | |
Sep 16 2016 | ESRX | Express Scripts Ho ... | MYERS WOODROW A JR | Director | Sell | S | 70.40 | 12,036 | 847,383 | 13,752 | 25.8 K to 13.8 K (-46.67 %) |
Sep 16 2016 | ESRX | Express Scripts Ho ... | MYERS WOODROW A JR | Director | Buy | M | 61.58 | 4,000 | 246,320 | 25,788 | 21.8 K to 25.8 K (+18.36 %) |
Sep 16 2016 | ESRX | Express Scripts Ho ... | MYERS WOODROW A JR | Director | Buy | M | 52.53 | 6,870 | 360,881 | 21,788 | 14.9 K to 21.8 K (+46.05 %) |
Sep 16 2016 | ESRX | Express Scripts Ho ... | MYERS WOODROW A JR | Director | Buy | M | 57.59 | 1,166 | 67,150 | 14,918 | 13.8 K to 14.9 K (+8.48 %) |
Sep 13 2016 | ESRX | Express Scripts Ho ... | Queller David A | Sr. VP, Sales and A ... | Payment of Exercise | F | 71.13 | 779 | 55,410 | 21,807 | 22.6 K to 21.8 K (-3.45 %) |
Sep 13 2016 | ESRX | Express Scripts Ho ... | Fotsch Donald | SVP, Home Del. & Me ... | Payment of Exercise | F | 71.13 | 333 | 23,686 | 10,360 | 10.7 K to 10.4 K (-3.11 %) |
Sep 13 2016 | ESRX | Express Scripts Ho ... | McGinnis Christopher A | VP, Controller & Ch ... | Sell | S | 70.77 | 1,785 | 126,324 | 3,170 | 5 K to 3.2 K (-36.02 %) |
Sep 13 2016 | ESRX | Express Scripts Ho ... | McGinnis Christopher A | VP, Controller & Ch ... | Payment of Exercise | F | 71.13 | 974 | 69,281 | 4,955 | 5.9 K to 5 K (-16.43 %) |
May 31 2016 | ESRX | Express Scripts Ho ... | Mergenthaler Frank | Director | Option Exercise | M | 30.83 | 4,748 | 146,381 | 0 | |
May 31 2016 | ESRX | Express Scripts Ho ... | Mergenthaler Frank | Director | Payment of Exercise | F | 74.97 | 1,953 | 146,416 | 24,724 | 26.7 K to 24.7 K (-7.32 %) |
May 31 2016 | ESRX | Express Scripts Ho ... | Mergenthaler Frank | Director | Buy | M | 30.83 | 4,748 | 146,381 | 26,677 | 21.9 K to 26.7 K (+21.65 %) |
May 11 2016 | ESRX | Express Scripts Ho ... | Neville Everett | Senior VP, Supply C ... | Sell | S | 74.11 | 800 | 59,288 | 13,835 | 14.6 K to 13.8 K (-5.47 %) |
May 09 2016 | ESRX | Express Scripts Ho ... | Neville Everett | Senior VP, Supply C ... | Payment of Exercise | F | 73.13 | 552 | 40,368 | 14,635 | 15.2 K to 14.6 K (-3.63 %) |
May 06 2016 | ESRX | Express Scripts Ho ... | MAC MAHON THOMAS P | Director | Option Exercise | A | 72.74 | 7,032 | 511,508 | 7,032 | |
May 06 2016 | ESRX | Express Scripts Ho ... | MAC MAHON THOMAS P | Director | Grant | A | 0.00 | 1,374 | 0 | 51,581 | 50.2 K to 51.6 K (+2.74 %) |
May 06 2016 | ESRX | Express Scripts Ho ... | LAHOWCHIC NICHOLAS | Director | Option Exercise | A | 72.74 | 7,032 | 511,508 | 7,032 | |
May 06 2016 | ESRX | Express Scripts Ho ... | LAHOWCHIC NICHOLAS | Director | Grant | A | 0.00 | 1,374 | 0 | 28,328 | 27 K to 28.3 K (+5.10 %) |
May 06 2016 | ESRX | Express Scripts Ho ... | DeLaney William J III | Director | Option Exercise | A | 72.74 | 7,032 | 511,508 | 7,032 | |
May 06 2016 | ESRX | Express Scripts Ho ... | DeLaney William J III | Director | Grant | A | 0.00 | 1,374 | 0 | 7,766 | 6.4 K to 7.8 K (+21.50 %) |
May 06 2016 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Option Exercise | A | 72.74 | 7,032 | 511,508 | 7,032 | |
May 06 2016 | ESRX | Express Scripts Ho ... | Breen Maura C | Director | Grant | A | 0.00 | 1,374 | 0 | 19,645 | 18.3 K to 19.6 K (+7.52 %) |
May 06 2016 | ESRX | Express Scripts Ho ... | BENANAV GARY G | Director | Option Exercise | A | 72.74 | 7,032 | 511,508 | 7,032 | |
May 06 2016 | ESRX | Express Scripts Ho ... | BENANAV GARY G | Director | Grant | A | 0.00 | 1,374 | 0 | 48,402 | 47 K to 48.4 K (+2.92 %) |
May 06 2016 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Option Exercise | A | 72.74 | 123,064 | 8,951,675 | 123,064 | |
May 06 2016 | ESRX | Express Scripts Ho ... | WENTWORTH TIMOTHY C | President & CEO | Grant | A | 0.00 | 24,058 | 0 | 153,616 | 129.6 K to 153.6 K (+18.57 %) |
May 06 2016 | ESRX | Express Scripts Ho ... | STERNBERG SEYMOUR | Director | Option Exercise | A | 72.74 | 7,032 | 511,508 | 7,032 |